On April 28, 2025, Quanterix Corp amended its merger agreement to acquire Akoya Biosciences, under which Akoya shareholders will receive 0.1461 shares of Quanterix stock and $0.38 cash for each share they own. This merger is a significant event as Quanterix will integrate Akoya into its structure, enhancing business operations.